img

Influenza Vaccine Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 88 | Industry : Food & Beverage

Publisher : 9 | Format : PDF

Influenza Vaccine Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Influenza Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Influenza Vaccine market segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others

Based on the end-use

the global Influenza Vaccine market classified into
Children
Adults
Elderly
Pregnancy

Based on geography

the global Influenza Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INFLUENZA VACCINE INDUSTRY
2.1 Summary about Influenza Vaccine Industry
2.2 Influenza Vaccine Market Trends
2.2.1 Influenza Vaccine Production & Consumption Trends
2.2.2 Influenza Vaccine Demand Structure Trends
2.3 Influenza Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Trivalent Influenza Vaccine
4.2.2 Quadrivalent Influenza Vaccine
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
4.3.3 Elderly
4.3.4 Pregnancy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.3.3 Elderly
5.3.4 Pregnancy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Trivalent Influenza Vaccine
6.2.2 Quadrivalent Influenza Vaccine
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.3.3 Elderly
6.3.4 Pregnancy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Trivalent Influenza Vaccine
7.2.2 Quadrivalent Influenza Vaccine
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.3.3 Elderly
7.3.4 Pregnancy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Trivalent Influenza Vaccine
8.2.2 Quadrivalent Influenza Vaccine
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.3.3 Elderly
8.3.4 Pregnancy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Trivalent Influenza Vaccine
9.2.2 Quadrivalent Influenza Vaccine
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.3.3 Elderly
9.3.4 Pregnancy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Sinovac
10.1.3 Changsheng
10.1.4 CCBIO
10.1.5 Aleph Biomedical
10.1.6 Sanofi
10.1.7 Lanzhou Institute Of Biological Product
10.1.8 Siobp
10.1.9 Hualan Bio
10.1.10 Tianyuan Bio-Pharma
10.1.11 Vaxtec
10.1.12 Hissen
10.1.13 Abbott
10.1.14 Novartis
10.1.15 Tasly&Jenner
10.1.16 Tiantan
10.2 Influenza Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Sinovac
10.2.3 Changsheng
10.2.4 CCBIO
10.2.5 Aleph Biomedical
10.2.6 Sanofi
10.2.7 Lanzhou Institute Of Biological Product
10.2.8 Siobp
10.2.9 Hualan Bio
10.2.10 Tianyuan Bio-Pharma
10.2.11 Vaxtec
10.2.12 Hissen
10.2.13 Abbott
10.2.14 Novartis
10.2.15 Tasly&Jenner
10.2.16 Tiantan
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Influenza Vaccine Product Type Overview
Table Influenza Vaccine Product Type Market Share List
Table Influenza Vaccine Product Type of Major Players
Table Brief Introduction of GSK
Table Brief Introduction of Sinovac
Table Brief Introduction of Changsheng
Table Brief Introduction of CCBIO
Table Brief Introduction of Aleph Biomedical
Table Brief Introduction of Sanofi
Table Brief Introduction of Lanzhou Institute Of Biological Product
Table Brief Introduction of Siobp
Table Brief Introduction of Hualan Bio
Table Brief Introduction of Tianyuan Bio-Pharma
Table Brief Introduction of Vaxtec
Table Brief Introduction of Hissen
Table Brief Introduction of Abbott
Table Brief Introduction of Novartis
Table Brief Introduction of Tasly&Jenner
Table Brief Introduction of Tiantan
Table Products & Services of GSK
Table Products & Services of Sinovac
Table Products & Services of Changsheng
Table Products & Services of CCBIO
Table Products & Services of Aleph Biomedical
Table Products & Services of Sanofi
Table Products & Services of Lanzhou Institute Of Biological Product
Table Products & Services of Siobp
Table Products & Services of Hualan Bio
Table Products & Services of Tianyuan Bio-Pharma
Table Products & Services of Vaxtec
Table Products & Services of Hissen
Table Products & Services of Abbott
Table Products & Services of Novartis
Table Products & Services of Tasly&Jenner
Table Products & Services of Tiantan
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Influenza Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Influenza Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f